Studies adult patients with status epilepticus to learn how their care affects outcomes
Observes adults with prolonged seizures to understand how treatment decisions affect their outcome.
Plain-language title generated from the registry record
Registry title: Status Epilepticus Population Study (STEPS)
Key facts
- Where
- Aarau and Basel, SwitzerlandSee the 2 sites
Where in Switzerland
- Cantonal Hospital Aarau (KSA)Aarau, SwitzerlandTaking people
- Clinic for Intensive Care Medicine, University Hospital BaselBasel, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Basel, Switzerland
- Trial code
- NCT04204863
- Record updated
- 17 June 2026
- Original description
The aim of this observational multicenter cohort study is to gain a deeper understanding regarding the effects of treatment adaption based on information from outcome prediction models, risk stratification, as well as treatment monitoring, detection, prevention, and management of complications on course and outcome of adult patients with status epilepticus (SE).Read full original descriptionShow less
Status Epilepticus Population Study (STEPS)
The aim of this observational multicenter cohort study is to gain a deeper understanding regarding the effects of treatment adaption based on information from outcome prediction models, risk stratification, as well as treatment monitoring, detection, prevention, and management of complications on course and outcome of adult patients with status epilepticus (SE).
Inclusion: Adult patients (i.e., patients ≥18 years of age) with diagnosed SE between 2005 and 2023 who have been treated at the University Hospital of Basel or the Cantonal Hospital Aarau.
Exclusion: Patients with repetitive epileptic seizures not qualifying for SE; Patients younger than 18 years; Patients with documented refusal of the general consent.